Michael Geschwind, MD, PhD

Phone: 415-476-2900
UCSF Box: 1207
Email: [email protected]
UCSF Profile

Project Sponsor Location(s) Topics Start
 		End
TLC-Pre-gPrd: Tracking Longitudinal Change in Presymptomatic genetic Prion Disease NIH National Institute on Aging United States Neurology and Mental Health
Predicting progression of human prion disease NIH National Institute on Aging United States Neurology and Mental Health, Dementia and Cognitive Impairment
Multi-center evaluation of improved RT-QuIC diagnostic assays for Creutzfeldt-Jakob and other human prion diseases United States Drug and Diagnostics Development, Neurology and Mental Health, Dementia and Cognitive Impairment
A Multicenter, Multinational, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Laquinimod (0.5, 1.0 and 1.5 mg/day) as Treatment in Patients with Huntington's Disease United States Neurology and Mental Health, Dementia and Cognitive Impairment
The Amyotrophic Lateral Sclerosis (ALS)/Parkinsonism-Dementia Complex of Guam: Exploring the Mechanism of a Rare Tauopathy CurePSP Northern Mariana Islands; Guam Genetics, Neurology and Mental Health
Predicting Progression of Human Prion Disease NIH National Institute on Aging United States Infectious Disease, Neurology and Mental Health
Neurobiological Predictors of Huntington's Disease (Predict-HD) University of Iowa United States Neurology and Mental Health
Early Diagnosis of Human Prion Disease NIH National Institute on Aging United States Infectious Disease, Drug and Diagnostics Development